SEED
NEUTRALSeed Innovations Provides Update on Investee Company Little Green Pharma
The investment company provides an update on its portfolio company, highlighting robust growth but lacking specific financial details or major news.
Seed Innovations
1.6000GBX
0.00%
Market Cap
3.09M
Volume
8.95M
2661% of avg
P/E Ratio
EPS (TTM)
N/A
Beta
N/A
Day Range
0.0000p - 0.0000p
52 Week Range
0.0000p1.6000p2.2000p
1.6000p
Upcoming Events
SEED
NEUTRALSeed Innovations Announces Director Shareholding Change
The asset management firm has disclosed a change in director shareholdings.
SEED
NEUTRALSeed Innovations Announces Holding Change
The asset management firm has announced a change in its major shareholding.
SEED
NEUTRALSeed Innovations Announces Director Shareholding Change
The asset management firm has disclosed a change in director shareholdings.
SEED
NEUTRALSEED Innovations Publishes New Corporate Presentation
The investment company has published a new corporate presentation on its website, providing investors with updated information on the business.
SEED
NEUTRALSeed Innovations Announces Change in Major Shareholding
The financial services firm announces a change in major shareholding, with a key investor increasing their stake.
SEED
GOODLittle Green Pharma Completes Acquisition of Medicinal Cannabis Distributor Health House
The life sciences investment company completes the acquisition of a leading medicinal cannabis distributor in Australia, strengthening its position in the rapidly growing market.
SEED
NEUTRALSEED Innovations: Notification of Major Shareholding Change
The retailer has announced a change in major shareholding, with no further details provided.
SEED
GOODLittle Green Pharma Delivers Impressive Q3 Results, Expands Rapidly in Europe
The retailer reported a 75% year-over-year increase in quarterly revenue, driven by strong growth in European markets and new product launches. The company's solid cash position and minimal debt reinforce its financial strength.
SEED
GOODSEED Innovations Outlines 2025 Strategy Amid Challenging 2024
The investment firm outlines its strategy for 2025, highlighting progress in its portfolio and a strong financial position, despite a challenging 2024.